Skip to main content

WELL Health Reports Record Canadian Patient Visits and Industry Leading Patient Satisfaction Metrics in 2025

  • WELL Canada’s patient services business delivered a record 4.3 million patient visits(1) in 2025, representing YoY growth of 37% and organic growth of 10%.
  • WELL’s Canadian clinic network maintained strong patient satisfaction scores in 2025. WELL's primary care network received an average Net Promoter Score(2) (NPS) of 80 based on 77,500 reviews in 2025 whereas WELL Health Diagnostics Centres received approximately 50,000 Google reviews with an average score of 4.8 to 4.9. These scores which index significantly above industry averages reflect the strength of WELL’s technology-enabled care delivery model.
  • WELL’s Canadian clinic network has now expanded to 252 clinics, adding 25 clinics in Q4-2025 and a total of 41 clinics in 2025, representing 19% YoY growth through clinic absorption and acquisition initiatives.
  • WELL’s Canadian network now includes over 3,100 providers, consisting of both billable and non-billable practitioners, representing 27% YoY growth.

WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide a corporate update on its Canadian Patient Services business, highlighting record patient visits, strong patient satisfaction scores, increasing clinic footprint, and a growing practitioner base across its national network in 2025.

Hamed Shahbazi, CEO of WELL, commented, “We are very proud of the accomplishments of our Canadian Patient Services network as it not only continues to grow and scale care efficiently across the country, but it also continues to receive substantially above average patient satisfaction scores. These results demonstrate that our technology enabled healthcare delivery network isn’t just bringing access and financial sustainability to the country’s healthcare ecosystem, but it is also delighting patients in the process. While we are pleased with our financial growth and progress, we know what is most important is building a trusted relationship with patients which can compound over time and transcend all delivery mediums.”

WELL Canada Patient Visits, Clinic Count and Healthcare Providers

 

2025

2024

Y/Y Growth

Annual Canada Patient Visits

4,279,513

3,124,631

37%

Canadian Clinic Counts (at year end)

252

211

19%

Canadian Providers (at year end)

3,119

2,567

27%

WELL Canada Patient Visits Annual Growth Breakdown

 

Y/Y growth

Same Clinic

4%

Absorption

6%

Total Organic

10%

Inorganic Growth

27%

Total Growth

37%

Record Patient Visits & Strong Patient Satisfaction Across Canadian Network

WELL delivered a record 4.3 million Canadian patient visits(1) in 2025, representing a 37% increase compared to the prior year and organic growth of 10%. Growth was driven by both organic means and inorganic strategic acquisitions, continued demand for primary care services, and improved clinic utilization and operational efficiencies enabled through WELL’s tech-enabled platforms.

Patient satisfaction across WELL’s Canadian clinic network also remains strong. WELL's primary care network received an average Net Promoter Score(2) (NPS) of 80 based on 77,500 reviews in 2025 whereas WELL Health Diagnostics Centres received approximately 50,000 Google reviews with an average score of 4.8 to 4.9. These scores which index significantly above industry averages reflect the strength of WELL’s technology-enabled care delivery model.

The sustained increase in patient volumes, together with strong patient experience scores, reflect WELL’s expanding role in improving access to care and supporting Canada’s public healthcare system. Demand for primary and specialty care services across Canada remains structurally strong, supported by population growth, physician supply constraints, and ongoing access challenges within the public healthcare system.

Expansion of National Clinic Network

WELL’s Canadian clinic network has now expanded to 252 clinics, adding 25 clinics in Q4-2025 and a total of 41 clinics in 2025, reflecting 19% YoY growth through clinic absorptions and acquisitions, and surpassing the milestone of over 250 clinics nationwide. The majority of these additions were completed in Ontario and Alberta, strengthening WELL’s regional density in two of Canada’s highest-demand healthcare markets. WELL continues to maintain a strong pipeline of acquisition and clinic absorption opportunities, supporting the ongoing expansion of its national clinic network and reinforcing its position as a trusted consolidator of outpatient healthcare assets in Canada.

Growth in Canadian Provider Base

WELL’s Canadian network now includes over 3,100 providers, consisting of both billable and non-billable practitioners, representing a 27% increase from 2024. The Company is pleased to report a 34% year-over-year increase in physicians joining the WELL network, representing the fastest-growing segment within its provider base. This growth reflects the Company’s continued investments in physician recruitment, onboarding, and practitioner enablement. The expansion of WELL’s practitioner network is strengthening access to primary care services across its national footprint and supporting the development of new patient panels in high-demand communities.

Shane Sabatino, Chief People Officer commented, “Healthcare providers are attracted to our platform because they are supported by a caring, committed and motivated workforce. I’m pleased to report that WELL Health Diagnostics has received a 4.3 star rating on ‘Indeed’ based on 371 reviews and WELL was once again certified as a 'Great Place to Work' employer in 2025 based on above average employee engagement levels as verified by an independent third party.”

WELL’s Canadian Patient Services platform continues to demonstrate strong operating momentum, supported by disciplined execution, organic growth initiatives, and ongoing investments in clinic absorption, digitization, and practitioner enablement. The Company remains focused on empowering healthcare providers with best-in-class digital tools while enhancing patient access, improving system efficiency, and delivering high-quality care at scale.

Footnotes:

  1. Patient visits are defined by any interaction a patient has with a WELL practitioner through all sources and channels. This also includes in-person, virtual, diagnostic testing consultations, and any asynchronous physician consultations.
  2. NPS, or Net Promoter Score, is a customer loyalty metric that measures how likely customers are to recommend a company’s products or services to others on a scale of -100 to 100. It is calculated based on responses to a single question: “How likely are you to recommend our service to a friend or colleague based on a scale of 0 to 10?” Such surveys are conducted 24 hours after a patient visit. The typical healthcare industry average in 2025 was slightly higher than a score of 50.
  3. Retently, ‘What is a Good Net Promoter Score? [2025 NPS Benchmarks],’ published on March 28, 2025.

WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director

About WELL Health Technologies Corp.

WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platforms include extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 43,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 250 clinics supporting primary care, specialized care, and diagnostic services. In the United States, WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and behavioral health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about WELL, please visit: www.well.company.

Forward-Looking Statements

This news release contains “Forward-Looking Information” within the meaning of applicable Canadian securities laws, including, without limitation the expectation that patient visits will continue to lead the way in driving strong organic growth for the Company enterprise wide. Forward-Looking Information is based on a number of estimates and assumptions are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond WELL’s control, which could cause actual results and events to differ materially from those disclosed in this news release. Forward-Looking Information generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “goal” or “continue”, or the negative thereof or similar variations. Forward-Looking Information involves known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information is not a guarantee of future results or performance. WELL’s comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL’s control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including, but not limited to: new technologies functioning as expected; customers adopting and using new technologies and services as expected; the need to develop increasingly innovative products and services; competition in the industry; the stability of general economic and market conditions; WELL’s ability to comply with applicable laws and regulations; WELL’s continued compliance with third party intellectual property rights; direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; litigation risk; that future results may vary from historical results; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent Annual Information Form and its most recent Management, Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.

Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Contacts

For further information:

Pardeep Sangha
Vice President Investor Relations
investor@well.company
604-628-7266

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.27
+0.00 (0.00%)
AAPL  266.18
+0.00 (0.00%)
AMD  196.60
+0.00 (0.00%)
BAC  51.07
+0.00 (0.00%)
GOOG  311.69
+0.00 (0.00%)
META  637.46
+0.21 (0.03%)
MSFT  384.47
+0.00 (0.00%)
NVDA  191.55
+0.00 (0.00%)
ORCL  141.31
+0.00 (0.00%)
TSLA  399.83
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.